Long-Term Survival, Safety and Tolerability with Selexipag in Patients with Pulmonary Arterial Hypertension: Results from GRIPHON and its Open-Label Extension

被引：0
|
作者：
Nazzareno Galiè
Sean Gaine
Richard Channick
J. Gerry Coghlan
Marius M. Hoeper
Irene M. Lang
Vallerie V. McLaughlin
Cheryl Lassen
Lewis J. Rubin
Shu-Fang Hsu Schmitz
Olivier Sitbon
Victor F. Tapson
Kelly M. Chin
机构：
[1] University of Bologna and IRCCS-S.Orsola University Hospital,Alma Mater Studiorum
[2] Mater Misericordiae University Hospital,David Geffen School of Medicine
[3] UCLA,undefined
[4] Royal Free Hospital,undefined
[5] Hannover Medical School and German Centre for Lung Research (DZL/BREATH),undefined
[6] Medical University of Vienna,undefined
[7] University of Michigan,undefined
[8] Actelion Pharmaceuticals Ltd,undefined
[9] University of California,undefined
[10] San Diego,undefined
[11] Hôpital Bicêtre,undefined
[12] Cedars-Sinai Medical Center,undefined
[13] University of Texas Southwestern Medical Center,undefined
[14] Université Paris-Sud,undefined
[15] INSERM Unité 999,undefined
来源：
Advances in Therapy | 2022年 / 39卷
关键词：
Selexipag; Pulmonary arterial hypertension; PAH; GRIPHON; Open-label extension; Safety; Tolerability; Survival; Combination therapy; Long-term outcomes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：796 / 810
页数：14
相关论文
共 50 条
  • [21] Long-term safety of a structured transition protocol from parenteral prostanoids to selexipag in pulmonary arterial hypertension
    Tamura, Yuichi
    Furukawa, Asuka
    Tamura, Yudai
    Yamada, Kenta
    Taniguchi, Hirohisa
    Fukuda, Keiichi
    Kawamura, Akio
    Satoh, Toru
    PULMONARY CIRCULATION, 2022, 12 (01)
  • [22] Long-term safety and efficacy of imatinib in pulmonary arterial hypertension
    Frost, Adaani E.
    Barst, Robyn J.
    Hoeper, Marius M.
    Chang, Hyuk-Jae
    Frantz, Robert P.
    Fukumoto, Yoshihiro
    Galie, Nazzareno
    Hassoun, Paul M.
    Klose, Hans
    Matsubara, Hiromi
    Morrell, Nicholas W.
    Peacock, Andrew J.
    Pfeifer, Michael
    Simonneau, Gerald
    Tapson, Victor F.
    Torres, Fernando
    Vizza, Carmine Dario
    Lawrence, David
    Yang, Wei
    Felser, James M.
    Quinn, Deborah A.
    Ghofrani, Hossein-Ardeschir
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (11) : 1366 - 1375
  • [23] Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension
    Humbert, Marc
    McLaughlin, Vallerie
    Gibbs, J. Simon R.
    Gomberg-Maitland, Mardi
    Hoeper, Marius M.
    Preston, Ioana R.
    Souza, Rogerio
    Waxman, Aaron B.
    Ghofrani, Hossein-Ardeschir
    Subias, Pilar Escribano
    Feldman, Jeremy
    Meyer, Gisela
    Montani, David
    Olsson, Karen M.
    Manimaran, Solaiappan
    Pena, Janethe de Oliveira
    Badesch, David B.
    EUROPEAN RESPIRATORY JOURNAL, 2023, 61 (01)
  • [24] Safety and tolerability of cariprazine in the long-term treatment of schizophrenia: results from a 48-week, single-arm, open-label extension study
    Durgam, Suresh
    Greenberg, William M.
    Li, Dayong
    Lu, Kaifeng
    Laszlovszky, Istvan
    Nemeth, Gyorgy
    Migliore, Raffaele
    Volk, Stephen
    PSYCHOPHARMACOLOGY, 2017, 234 (02) : 199 - 209
  • [25] Long-term effects of evolocumab in participants with HIV and dyslipidemia: results from the open-label extension period
    Boccara, Franck
    Caramelli, Bruno
    Calmy, Alexandra
    Kumar, Princy
    Lopez, J. Antonio G.
    Bray, Sarah
    Cyrille, Marcoli
    Rosenson, Robert S.
    AIDS, 2022, 36 (05) : 675 - 682
  • [26] Long-term safety of brodalumab in Japanese patients with plaque psoriasis: An open-label extension study
    Yamaguchi, Yukie
    Takatsu, Nobumichi
    Ootaki, Kenji
    Nakagawa, Hidemi
    JOURNAL OF DERMATOLOGY, 2020, 47 (06) : 569 - 577
  • [27] Long-term tolerability and efficacy of golimumab in active non-radiographic axial spondyloarthritis: results from open-label extension
    van der Heijde, Desiree
    Dougados, Maxime
    Maksymowych, Walter P.
    Bergman, Gina
    Curtis, Sean P.
    Tzontcheva, Anjela
    Huyck, Susan
    Philip, George
    Sieper, Joachim
    RHEUMATOLOGY, 2022, 61 (02) : 617 - 627
  • [28] Safety and tolerability of cariprazine in the long-term treatment of schizophrenia: results from a 48-week, single-arm, open-label extension study
    Suresh Durgam
    William M. Greenberg
    Dayong Li
    Kaifeng Lu
    Istvan Laszlovszky
    Gyorgy Nemeth
    Raffaele Migliore
    Stephen Volk
    Psychopharmacology, 2017, 234 : 199 - 209
  • [29] Clinical efficacy, safety, tolerability, and survival outcome of long-term inhaled iloprost treatment in the management of pulmonary arterial hypertension: Data from prospective multicenter observational OPTION study
    Kucukoglu, Mehmet Serdar
    Hanta, Ismail
    Akdeniz, Bahri
    Gullulu, Sumeyye
    Atahan, Ersan
    Sayin, Tamer
    Okumus, Gulfer
    Onen, Zeynep Pinar
    Yokusoglu, Mehmet
    Baygul, Arzu
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2021, 25 (10) : 721 - 732
  • [30] Assessment of prolonged safety and tolerability of erenumab in migraine patients in a long-term open-label study (APOLLON)
    Goebel, Hartmut
    Schlegel, Eugen
    Jaeger, Kathrin
    Ortler, Sonja
    Leist, Lea
    JOURNAL OF HEADACHE AND PAIN, 2024, 25 (01)
12345